These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16768699)

  • 1. Advances in the adjuvant treatment of colorectal cancer.
    Nordman IC; Iyer S; Joshua AM; Clarke SJ
    ANZ J Surg; 2006 May; 76(5):373-80. PubMed ID: 16768699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for colon cancer: present and perspectives.
    De Dosso S; Sessa C; Saletti P
    Cancer Treat Rev; 2009 Apr; 35(2):160-6. PubMed ID: 19013023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
    J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for colon cancer.
    Pallis AG; Mouzas IA
    Anticancer Res; 2006; 26(6C):4809-15. PubMed ID: 17214345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy in colon cancer.
    Graham JS; Cassidy J
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):99-109. PubMed ID: 22149436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
    Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.
    Samantas E; Dervenis C; Rigatos SK
    Dig Dis; 2007; 25(1):67-75. PubMed ID: 17384510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
    Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
    Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of older age on the efficacy of newer adjuvant chemotherapy regimens in colon cancer, a subgroup analysis of a meta-analysis: Practice changing? Certainly not; Hypothesis generating? Perhaps.
    Copur MS
    Clin Colorectal Cancer; 2009 Oct; 8(4):190-1. PubMed ID: 19822507
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted agents for adjuvant therapy of colon cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
    Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
    J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.